Gabriel Kaleb Martins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gabriel Kaleb Martins has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Maria Eduarda Dantas de Souza Reis
Instituto de Educação Médica
7 shared publications - Arina Peixoto Nobre
Universidade de Fortaleza, Brasil
5 shared publications - Cláudio Firmino Dantas
Instituto de Educação Médica
4 shared publications - João Victor Victor Lopes Lima
Santa Casa de Misericórdia de Feira de Santana
3 shared publications - Maikon Lucian Madeira Quarti
Hospital e Maternidade Marieta Konder Bornhausen, Brasil
3 shared publications - Maria Rayane Félix Pacífico
Instituto de Educação Médica
3 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38
Institutional volume and postoperative efficiency as determinants of in-hospital mortality after coronary artery bypass grafting: a multilevel analysis in São Paulo, Brazil
Objective To evaluate the association between hospital procedural volume, postoperative efficiency, and in-hospital mortality and costs among patients undergoing coronary artery bypass grafting in the public health system of the State of São Paulo, Brazil. Methods This retrospective ecological study analyzed isolated coronary artery bypass grafting procedures recorded in the Brazilian Hospital Information System […] ABSTRACT Objective To evaluate the association between hospital procedural volume, postoperative efficiency, and in-hospital mortality and costs among patients undergoing coronary artery bypass grafting in the public health system of the State of São Paulo, Brazil. Methods This retrospective ecological study analyzed isolated coronary artery bypass grafting procedures recorded in the Brazilian Hospital Information System […]
- 8 October 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38
Open AccessInstitutional volume and postoperative efficiency as determinants of in-hospital mortality after coronary artery bypass grafting: a multilevel analysis in São Paulo, Brazil
Objective To evaluate the association between hospital procedural volume, postoperative efficiency, and in-hospital mortality and costs among patients undergoing coronary artery bypass grafting in the public health system of the State of São Paulo, Brazil. Methods This retrospective ecological study analyzed isolated coronary artery bypass grafting procedures recorded in the Brazilian Hospital Information System […] ABSTRACT Objective To evaluate the association between hospital procedural volume, postoperative efficiency, and in-hospital mortality and costs among patients undergoing coronary artery bypass grafting in the public health system of the State of São Paulo, Brazil. Methods This retrospective ecological study analyzed isolated coronary artery bypass grafting procedures recorded in the Brazilian Hospital Information System […]
- Open Access
- 29 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Mudança dos Padrões da Mortalidade Fora do Hospital e da Perda Prematura de Vida em Cardiomiopatias: Um Estudo Nacional Baseado em População
Fundamento: As cardiomiopatias são uma importante causa de mortalidade cardiovascular, apresentando fenótipos dependentes da idade que variam desde morte súbita cardíaca (MSC) até insuficiência cardíaca progressiva. Apesar da queda nas taxas de mortalidade, lacunas na prevenção e no acesso a terapias avançadas podem se manifestar como mudanças no local do óbito e persistência de mortalidade prematura. Objetivos: Avaliar tendências temporais da mortalidade relacionada às cardiomiopatias no Brasil, examinar padrões etários no local do óbito e quantificar a mortalidade prematura por meio dos anos de vida perdidos (AVP). Métodos: Este estudo ecológico nacional, baseado em população, analisou 369 570 óbitos no Brasil (1996–2024) em que a cardiomiopatia (CID-10 I42) foi a causa básica. Tendências temporais foram avaliadas por regressão de Poisson, e associações entre idade e local do óbito foram estimadas por razões de chances (OR). Os AVP foram calculados utilizando tábuas de vida nacionais. Resultados: A mortalidade ajustada por idade diminuiu 1,7% ao ano (p<0,001). Óbitos hospitalares caíram de 75% para 43%, enquanto óbitos domiciliares aumentaram de 20% para 38%, com ponto de inflexão significativo por volta de 2011. Óbitos em vias públicas, usados como proxy de MSC, foram mais frequentes entre adultos de 20–39 anos (4,8%) do que entre aqueles com ≥60 anos (0,8%; OR 2,88; IC 95% 2,68–3,10). O total de AVP atingiu 6,83 milhões de anos. Indivíduos de 20–39 anos representaram apenas 5,5% dos óbitos, mas contribuíram com 12,8% dos AVP totais, com média de 42,9 anos perdidos por óbito. Conclusões: Apesar da queda na mortalidade, óbitos fora do ambiente hospitalar tornaram-se mais frequentes. O excesso de AVP entre adultos jovens evidencia lacunas na prevenção da MSC. Estratégias específicas por faixa etária são necessárias para reduzir a mortalidade prematura.
- 29 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Open AccessMudança dos Padrões da Mortalidade Fora do Hospital e da Perda Prematura de Vida em Cardiomiopatias: Um Estudo Nacional Baseado em População
Fundamento: As cardiomiopatias são uma importante causa de mortalidade cardiovascular, apresentando fenótipos dependentes da idade que variam desde morte súbita cardíaca (MSC) até insuficiência cardíaca progressiva. Apesar da queda nas taxas de mortalidade, lacunas na prevenção e no acesso a terapias avançadas podem se manifestar como mudanças no local do óbito e persistência de mortalidade prematura. Objetivos: Avaliar tendências temporais da mortalidade relacionada às cardiomiopatias no Brasil, examinar padrões etários no local do óbito e quantificar a mortalidade prematura por meio dos anos de vida perdidos (AVP). Métodos: Este estudo ecológico nacional, baseado em população, analisou 369 570 óbitos no Brasil (1996–2024) em que a cardiomiopatia (CID-10 I42) foi a causa básica. Tendências temporais foram avaliadas por regressão de Poisson, e associações entre idade e local do óbito foram estimadas por razões de chances (OR). Os AVP foram calculados utilizando tábuas de vida nacionais. Resultados: A mortalidade ajustada por idade diminuiu 1,7% ao ano (p<0,001). Óbitos hospitalares caíram de 75% para 43%, enquanto óbitos domiciliares aumentaram de 20% para 38%, com ponto de inflexão significativo por volta de 2011. Óbitos em vias públicas, usados como proxy de MSC, foram mais frequentes entre adultos de 20–39 anos (4,8%) do que entre aqueles com ≥60 anos (0,8%; OR 2,88; IC 95% 2,68–3,10). O total de AVP atingiu 6,83 milhões de anos. Indivíduos de 20–39 anos representaram apenas 5,5% dos óbitos, mas contribuíram com 12,8% dos AVP totais, com média de 42,9 anos perdidos por óbito. Conclusões: Apesar da queda na mortalidade, óbitos fora do ambiente hospitalar tornaram-se mais frequentes. O excesso de AVP entre adultos jovens evidencia lacunas na prevenção da MSC. Estratégias específicas por faixa etária são necessárias para reduzir a mortalidade prematura.
- Open Access
- 29 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Shifting Patterns of Out-Of-Hospital Mortality and Premature Life Loss in Cardiomyopathies: A Nationwide Population-Based Study
Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based [...] Abstract Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based
- 29 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Open AccessShifting Patterns of Out-Of-Hospital Mortality and Premature Life Loss in Cardiomyopathies: A Nationwide Population-Based Study
Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based [...] Abstract Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based
- 20 June 2026
- Published by Elsevier in Canadian Journal of Cardiology
Efficacy-Effectiveness Gaps in Composite Grafting Within Heterogeneous Systems
- 20 June 2026
- Published by Elsevier in Canadian Journal of Cardiology
Efficacy-Effectiveness Gaps in Composite Grafting Within Heterogeneous Systems
- 15 June 2026
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
Hospital Admissions for Cleft Lip and Palate in Brazil (2008–2024): Temporal Trends, Racial Disparities, and Regional Efficiency Clusters
Objective: To describe temporal trends in hospital admissions for cleft lip and/or palate (CL/P) repair in Brazil, assess the COVID-19 pandemic impact, examine racial and demographic disparities in length of hospital stay (LOS), and identify regional efficiency patterns. Design: Retrospective ecological study using nationwide hospital admission data. Setting: Brazilian Unified Health System (SUS), covering public sector inpatient procedures. Participants: 98,998 hospital admissions for CL/P surgical repair from 2008 to 2024. Interventions: None (observational analysis of primary/secondary surgical repairs). Main Outcome Measures: Annual admission volumes and trends (annual percent change via Prais–Winsten regression); LOS by race/color (Kruskal–Wallis test); state-level clustering (K-means) based on volume, sex distribution, and mean LOS. Results: Male predominance (ratio 1.36:1); 70% repairs under age 5. Stable volumes until 33% decline in 2020, with incomplete recovery. Significant racial disparities in LOS ( p = .0007), longer among Brown (Parda) and Indigenous children. Heterogeneous state trends; four clusters identified, with São Paulo high-volume/moderate-stay vs. northern low-volume/prolonged-stay. Conclusions: Brazil has robust CL/P surgical capacity, but racial and profound regional disparities persist, compromising equity and efficiency. Targeted investment in northern regions, decentralized expertise, and standardized protocols are needed to reduce inequities.
- 15 June 2026
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
Hospital Admissions for Cleft Lip and Palate in Brazil (2008–2024): Temporal Trends, Racial Disparities, and Regional Efficiency Clusters
Objective: To describe temporal trends in hospital admissions for cleft lip and/or palate (CL/P) repair in Brazil, assess the COVID-19 pandemic impact, examine racial and demographic disparities in length of hospital stay (LOS), and identify regional efficiency patterns. Design: Retrospective ecological study using nationwide hospital admission data. Setting: Brazilian Unified Health System (SUS), covering public sector inpatient procedures. Participants: 98,998 hospital admissions for CL/P surgical repair from 2008 to 2024. Interventions: None (observational analysis of primary/secondary surgical repairs). Main Outcome Measures: Annual admission volumes and trends (annual percent change via Prais–Winsten regression); LOS by race/color (Kruskal–Wallis test); state-level clustering (K-means) based on volume, sex distribution, and mean LOS. Results: Male predominance (ratio 1.36:1); 70% repairs under age 5. Stable volumes until 33% decline in 2020, with incomplete recovery. Significant racial disparities in LOS ( p = .0007), longer among Brown (Parda) and Indigenous children. Heterogeneous state trends; four clusters identified, with São Paulo high-volume/moderate-stay vs. northern low-volume/prolonged-stay. Conclusions: Brazil has robust CL/P surgical capacity, but racial and profound regional disparities persist, compromising equity and efficiency. Targeted investment in northern regions, decentralized expertise, and standardized protocols are needed to reduce inequities.
- Open Access
- 2 March 2026
- Published by Elsevier in SSRN Electronic Journal
Acute and Long-Term Protection Against Aortic Mortality through BCG and Yellow Fever Vaccination: A 29-Year Causal Inference Analysis
AimsDiseases of the aorta are driven by chronic inflammation and matrix metalloproteinase activity. Vaccines like Yellow Fever (YF) and BCG may confer vascular protection through "trained immunity" epigenetic reprogramming of innate immune cells that attenuates systemic inflammatory responses. It was investigated the association between population-level vaccination coverage and aortic mortality using contemporary causal inference methods.Methods and ResultsThis ecological study analyzed 27 Brazilian states over 29 years (1994–2022), encompassing 783 state-year observations and 185,429 deaths. It was employed Poisson fixed-effects models with state and year intercepts to isolate within-state effects. States with high YF coverage (>80%) showed a 16% reduction in age-standardized aortic mortality compared to low-coverage states (IRR 0.84; 95% CI 0.76–0.93; P=0.001). E-value analysis for this association was 1.67, indicating robustness against unmeasured confounders. For BCG, protective effects followed a biologically plausible lag structure, peaking at 15 years post-vaccination (IRR 0.91 per 10pp increase; 95% CI 0.85–0.98; P=0.009). Negative control analysis using Diphtheria-Tetanus-Pertussis (DTP) vaccine, which lacks trained immunity effects, showed no association with aortic mortality (IRR 1.02; P=0.578), arguing against residual confounding from healthcare access. Causal mediation analysis revealed that 65% of the YF vaccine’s effect operated through direct vascular pathways independent of infectious disease reduction.ConclusionPopulation-level vaccination with YF and BCG is associated with significant acute and long-term reductions in aortic mortality. These findings, supported by negative control validation and temporal consistency across three decades, suggest that vaccine-induced trained immunity may be a modifiable factor in preventing aortic wall degradation.
- 2 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAcute and Long-Term Protection Against Aortic Mortality through BCG and Yellow Fever Vaccination: A 29-Year Causal Inference Analysis
AimsDiseases of the aorta are driven by chronic inflammation and matrix metalloproteinase activity. Vaccines like Yellow Fever (YF) and BCG may confer vascular protection through "trained immunity" epigenetic reprogramming of innate immune cells that attenuates systemic inflammatory responses. It was investigated the association between population-level vaccination coverage and aortic mortality using contemporary causal inference methods.Methods and ResultsThis ecological study analyzed 27 Brazilian states over 29 years (1994–2022), encompassing 783 state-year observations and 185,429 deaths. It was employed Poisson fixed-effects models with state and year intercepts to isolate within-state effects. States with high YF coverage (>80%) showed a 16% reduction in age-standardized aortic mortality compared to low-coverage states (IRR 0.84; 95% CI 0.76–0.93; P=0.001). E-value analysis for this association was 1.67, indicating robustness against unmeasured confounders. For BCG, protective effects followed a biologically plausible lag structure, peaking at 15 years post-vaccination (IRR 0.91 per 10pp increase; 95% CI 0.85–0.98; P=0.009). Negative control analysis using Diphtheria-Tetanus-Pertussis (DTP) vaccine, which lacks trained immunity effects, showed no association with aortic mortality (IRR 1.02; P=0.578), arguing against residual confounding from healthcare access. Causal mediation analysis revealed that 65% of the YF vaccine’s effect operated through direct vascular pathways independent of infectious disease reduction.ConclusionPopulation-level vaccination with YF and BCG is associated with significant acute and long-term reductions in aortic mortality. These findings, supported by negative control validation and temporal consistency across three decades, suggest that vaccine-induced trained immunity may be a modifiable factor in preventing aortic wall degradation.
- 27 February 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
The shadow of non-enrolment: structural vulnerability and equity in cardiovascular registries
Gabriel Kaleb Martins; The Shadow of Non-Enrolment: Structural Vulnerability and Equity in Cardiovascular Registries, European Heart Journal - Quality of C
- 27 February 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
The shadow of non-enrolment: structural vulnerability and equity in cardiovascular registries
Gabriel Kaleb Martins; The Shadow of Non-Enrolment: Structural Vulnerability and Equity in Cardiovascular Registries, European Heart Journal - Quality of C
- Open Access
- 20 February 2026
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 45 (6) , 331-332
Sex imbalance in a large Fontan cohort: Biological reality or marker of inequitable care?
- 20 February 2026
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 45 (6) , 331-332
Open AccessSex imbalance in a large Fontan cohort: Biological reality or marker of inequitable care?
- Open Access
Development Efficiency and Mortality After Coronary Artery Bypass Grafting: A National Causal Inference Analysis
Background: We evaluated whether development efficiency, the component of the Human Development Index independent of GDP per capita and income inequality, is associated with in-hospital mortality after coronary artery bypass grafting (CABG) in Brazil, and whether this association is mediated by access to elective surgery. Methods: We conducted a retrospective ecological panel study using administrative data on CABG hospitalizations within the Brazilian Unified Health System from 2008-2024. State-year observations were linked to socioeconomic indicators. Development efficiency was defined as the residual of HDI after regression on GDP per capita and the Gini coefficient. Associations with in-hospital mortality were examined using volume-weighted multilevel models. Absolute causal effects and mediation through urgency status were estimated using g-computation and parametric causal mediation analysis. Results: The final analytic panel included 379 state-year observations. A 1–standard deviation increase in development efficiency was associated with a reduction in predicted in-hospital mortality from 6.8% to 5.7% (absolute risk reduction −1.1 percentage points; p<0.001), corresponding to one death prevented for every 91 procedures. Mediation analysis indicated that 95.5% of the total effect was attributable to the natural direct effect, while only 4.5% was mediated through urgency status, with no significant indirect effect. Conclusions: Development efficiency is an independent and clinically meaningful determinant of survival after CABG in Brazil. Higher income-independent HDI performance is associated with substantial absolute mortality reductions, driven predominantly by direct system-level pathways rather than changes in urgency profile. Strengthening health-system efficiency and perioperative capacity may therefore yield meaningful gains in cardiac surgical outcomes.
Open AccessDevelopment Efficiency and Mortality After Coronary Artery Bypass Grafting: A National Causal Inference Analysis
Background: We evaluated whether development efficiency, the component of the Human Development Index independent of GDP per capita and income inequality, is associated with in-hospital mortality after coronary artery bypass grafting (CABG) in Brazil, and whether this association is mediated by access to elective surgery. Methods: We conducted a retrospective ecological panel study using administrative data on CABG hospitalizations within the Brazilian Unified Health System from 2008-2024. State-year observations were linked to socioeconomic indicators. Development efficiency was defined as the residual of HDI after regression on GDP per capita and the Gini coefficient. Associations with in-hospital mortality were examined using volume-weighted multilevel models. Absolute causal effects and mediation through urgency status were estimated using g-computation and parametric causal mediation analysis. Results: The final analytic panel included 379 state-year observations. A 1–standard deviation increase in development efficiency was associated with a reduction in predicted in-hospital mortality from 6.8% to 5.7% (absolute risk reduction −1.1 percentage points; p<0.001), corresponding to one death prevented for every 91 procedures. Mediation analysis indicated that 95.5% of the total effect was attributable to the natural direct effect, while only 4.5% was mediated through urgency status, with no significant indirect effect. Conclusions: Development efficiency is an independent and clinically meaningful determinant of survival after CABG in Brazil. Higher income-independent HDI performance is associated with substantial absolute mortality reductions, driven predominantly by direct system-level pathways rather than changes in urgency profile. Strengthening health-system efficiency and perioperative capacity may therefore yield meaningful gains in cardiac surgical outcomes.